Clinical Trial Update: 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs [Phase 2]

View source ↗

Summary

A Phase 2, multi-center 4-week dose-ranging trial evaluating tenapanor for irritable bowel syndrome with constipation in children aged 6 to <12 years is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Tenapanor (tenapanor)

Snippet

Sponsor: Ardelyx | Conditions: Irritable Bowel Syndrome With Constipation (IBS-C) | Phase 2 | Status: RECRUITING